MORGAN STANLEY PLC/PUT/MERCK & CO./100/0.1/20.09.24 | Real-time Bid/Ask 06:34:09 17/06/2024 pm IST | ||
| 0.04 EUR / 0.057 EUR | +11.36% |
|
| Current month | -22.81% | ||
| 1 month | -18.52% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 17/24/17 | 0.039 | -11.36% |
| 14/24/14 | 0.044 | 0.00% |
| 13/24/13 | 0.044 | +4.76% |
| 12/24/12 | 0.042 | +2.44% |
| 11/24/11 | 0.041 | -2.38% |
Delayed Quote Börse Stuttgart
Last update June 17, 2024 at 04:50 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Morgan Stanley |
| WKN | MB0FEK |
| ISIN | DE000MB0FEK2 |
| Date issued | 10/11/2022 |
| Strike | 100 $ |
| Maturity | 20/09/2024 (95 Days) |
| Parity | 10 : 1 |
| Emission price | 1.35 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.3 € |
|---|---|
| Lowest since issue | 0.023 € |
| Spread | 0.024 € |
| Spread % | 38.10% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.5
USD
Average target price
142.7
USD
Spread / Average Target
+10.20%
- Stock Market
- Warrants
- Warrant
